Factors determining the oral absorption and systemic disposition of zeaxanthin in rats: in vitro, in situ, and in vivo evaluations

Determination of Leuprolide-Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in Rats

Fractional transit compartment model for describing drug delayed response to tumors using Mittag-Leffler distribution on age- structured PKPD model

A simple and sensitive HPLC-FL method for bioanalysis of velpatasvir, a novel hepatitis C virus NS5A inhibitor, in rat plasma: Investigation of factors determining its oral bioavailability

Impact of route-dependent phase-II gut metabolism and enterohepatic circulation on the bioavailability and systemic disposition of resveratrol in rats and humans: A comprehensive whole body physiologically-based pharmacokinetic modeling

Extended transit compartment model to describe tumor delay using Coxian distribution

Development and application of a physiologically based pharmacokinetic model for entrectinib in rats and scale-up to humans: Route-dependent gut wall metabolism

Differential effects of 1α,25-dihydroxyvitamin D<inf>3</inf> on the expressions and functions of hepatic CYP and UGT enzymes and its pharmacokinetic consequences in vivo

Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D <inf>3</inf> : Effects on in vivo oral absorption and disposition of buspirone in rats

Assessment of pharmacokinetics, bioavailability and protein binding of anacetrapib in rats by a simple high-performance liquid chromatography-tandem mass spectrometry method